A 5-biomarker panel of cervico-vaginal fluid proteins combining APOE, GGCT, CFAB, LY6D and CEAM5 predicted advanced stage endometrial cancer with AUC 0.96 (0.92–1.00). This evidence concerns the gene LY6D and endometrial cancer.